NCT00589771 - Saccharomyces Boulardii in Irritable Bowel Syndrome | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

Diarrhea Dominant Irritable Bowel Syndrome

Interventions

DRUG

Saccharomyces boulardii

"1. Saccharomyces boulardii one capsule 250mg TDS for 6 weeks~2. Ispaghula husk 1 Tsf daily after dinner for six weeks"

DRUG

Placebo

"1. Cap Placebo TDS for six weeks~2. Ispaghula husk 1 Tsf daily after dinner for six weeks"

Trial Locations (1)

Aga Khan University Hospital, Karachi